[Thromboprophylaxis in pregnant women should be individually tailored].

There is no fulltext present in this item.

Title:	[Thromboprophylaxis in pregnant women should be individually tailored].
Author(s):	Spaanderman, M.E.A.
Publication year:	2011
Source:	Nederlands Tijdschrift voor Geneeskunde, vol. 155, iss. 18, (2011), pp. A3568
ISSN:	0028-2162
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/98550
Display more details
Subject:	NCEBP 14: Cardiovascular diseases
Organization:	Gynaecology
Journal title:	Nederlands Tijdschrift voor Geneeskunde
Volume:	vol. 155
Issue:	iss. 18
Page start:	p. A3568
Page end:	p. A3568
Abstract:	Roeters van Lennep et al. recently evaluated efficacy and safety of thromboprophylaxis with low dose low-molecular-weight heparin (LMWH) in women with intermediate and high risk of pregnancy-related venous thromboembolism (VTE). Lessons to be drawn from this study are that the risk of VTE should be estimated preconceptionally, that the current LMWH prophylaxis is sufficient during pregnancy and the post-partum period for women with an intermediate risk of VTE, that from a haemostatic point of view the post-partum period does not end at 6 weeks but at 3 months, and that the prophylactic LMWH dosage is insufficient in 1 out of 20 women with a high risk of VTE.